Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

In search of natural substrates and inhibitors of MDR pumps.

Lewis K.

J Mol Microbiol Biotechnol. 2001 Apr;3(2):247-54. Review.

PMID:
11321580
2.

Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor.

Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K.

Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1433-7.

3.

Conjugating berberine to a multidrug efflux pump inhibitor creates an effective antimicrobial.

Ball AR, Casadei G, Samosorn S, Bremner JB, Ausubel FM, Moy TI, Lewis K.

ACS Chem Biol. 2006 Oct 24;1(9):594-600.

PMID:
17168555
4.

Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials.

Tegos G, Stermitz FR, Lomovskaya O, Lewis K.

Antimicrob Agents Chemother. 2002 Oct;46(10):3133-41.

5.

Multidrug resistance pumps in bacteria: variations on a theme.

Lewis K.

Trends Biochem Sci. 1994 Mar;19(3):119-23. Review.

PMID:
8203018
6.

EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB.

Lomovskaya O, Lewis K, Matin A.

J Bacteriol. 1995 May;177(9):2328-34.

8.

[The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].

Hasdemir U.

Mikrobiyol Bul. 2007 Apr;41(2):309-27. Review. Turkish.

PMID:
17682720
9.

[Efflux-mediated antibiotics resistance in bacteria].

Cattoir V.

Pathol Biol (Paris). 2004 Dec;52(10):607-16. French.

PMID:
15596311
10.

Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.

Wieczorek P, Sacha P, Hauschild T, Zórawski M, Krawczyk M, Tryniszewska E.

Folia Histochem Cytobiol. 2008;46(3):257-67. doi: 10.2478/v10042-008-0056-x. Review.

11.

Berberis aetnensis C. Presl. extracts: antimicrobial properties and interaction with ciprofloxacin.

Musumeci R, Speciale A, Costanzo R, Annino A, Ragusa S, Rapisarda A, Pappalardo MS, Iauk L.

Int J Antimicrob Agents. 2003 Jul;22(1):48-53.

PMID:
12842327
12.

Bacteria lacking a multidrug pump: a sensitive tool for drug discovery.

Hsieh PC, Siegel SA, Rogers B, Davis D, Lewis K.

Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6602-6.

13.

Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.

Rieg S, Huth A, Kalbacher H, Kern WV.

Int J Antimicrob Agents. 2009 Feb;33(2):174-6. doi: 10.1016/j.ijantimicag.2008.07.032.

PMID:
18945595
14.

Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria.

Lomovskaya O, Watkins W.

J Mol Microbiol Biotechnol. 2001 Apr;3(2):225-36. Review.

PMID:
11321578
15.

Antibiotic efflux pumps.

Van Bambeke F, Balzi E, Tulkens PM.

Biochem Pharmacol. 2000 Aug 15;60(4):457-70. Review.

PMID:
10874120
16.

Bacterial efflux pump inhibitors from natural sources.

Stavri M, Piddock LJ, Gibbons S.

J Antimicrob Chemother. 2007 Jun;59(6):1247-60. Review.

17.
18.

The Escherichia coli multidrug transporter MdfA catalyzes both electrogenic and electroneutral transport reactions.

Lewinson O, Adler J, Poelarends GJ, Mazurkiewicz P, Driessen AJ, Bibi E.

Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1667-72.

19.

Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).

Bohnert JA, Schuster S, Fähnrich E, Trittler R, Kern WV.

J Antimicrob Chemother. 2007 Jun;59(6):1216-22.

20.
Items per page

Supplemental Content

Support Center